showed that taurine treatment on SpragueDawley rats can lead to a notable increase in cerebral blood flow of damaged ipsilateral and contralateral brain cortex at 30 min after traumatic brain injury (114)
The duration of BPC-157 use for bone healing depends on the severity of the injury or surgery and the patients individual response to treatment
Crosses the Blood-Brain Barrier Unlike many peptides and growth factors, Dihexa is orally bioavailable and crosses the BBB , meaning it can be taken as an oral tablet and still reach brain tissues in therapeutic concentrations
The peptide enhances all phases of the healing process, including inflammatory phase modulation , proliferative phase stimulation , and remodeling phase optimization
We screen carefully for contraindications and monitor labs and symptoms
Some providers recommend injecting BPC-157 near the site of injury for localized effect, while TB-500 is injected subcutaneously in the abdominal area for systemic distribution